




 |
Services offered by Applied
Regulatory Consulting
|
|
The following services are offered by Applied
Regulatory Consulting. These are provided as typical ways we can
help our clients and are not intended to be exhaustive. If you
would like to know more about how Applied Regulatory Consulting
can help you with your particular projects, please do not
hesitate to contact us. |
 |
Regulatory strategy - to optimise
the approach to achieve the best possible registration outcome. This
includes an evaluation of the different regulatory procedures
available
Product development - preparation
and review of product development plans with attention to pharmaceutical, pharmacotoxicological and clinical aspects
Regulatory due diligence - due
diligence reviews for suitability for acquisitions, co-marketing and
licensing opportunities for marketed products and those in
development, and for company acquisitions
Regulatory intelligence -
including desk-based research to establish the regulatory
environment and precedents for your particular product
Return to top
of page
Formal and informal contact with
regulatory agencies
Interpreting the position of regulatory
agencies
Agency meetings (including preparation,
coaching and help with associated documentation)
-
Liaison with the EMEA's SME Office (including
Scientific Advice and Protocol Assistance)
Responses to regulatory agencies
Strategy for approaching agencies
Knowing which questions are the right
ones
Return to top
of page
Seminars and lectures on regulatory
topics
Training programmes
Management guidance on regulatory
operations, including the set up, resource planning and
team-building of regulatory affairs departments
-
Interim management and mentoring
Return to top
of page
Project planning
Project leadership
Regulatory input for project teams
Critical path analysis for product
development plans
Submission planning and preparation
Return to top
of page
Clinical trials applications
Marketing applications (including MAA's
via Mutual Recognition and Centralised EU procedures, NDA's etc.)
CTD formats
Orphan medicinal product designation
applications
Return to
top of page
Return to top
of page
|